Grifols

Strong Historical Occupancy: Biomat USA Plasma Center has operated from the Property since 2012 on a long-term NNN lease featuring two (2), five-year renewal option periods and attractive 3.00% annual rental escalations.
Corporate Lease with Grifols: Grifols is a global biopharma company focused on plasma-derived medicines, and hospital/pharma services. Grifols is the largest plasma donation network in the world with 400 + centers located across North America, Europe, Africa/Middle East, and China. The company employs over 23,000 worldwide.
Strong Global Revenue: Grifols reported $8.3 Billion USD in revenue for 2025, a 7.00% year-over-year increase.
Strategic Investment in Biomat USA Platform: In 2021, sovereign wealth fund GIC invested approximately $1 billion into Biomat USA, validating the value of the U.S. plasma collection platform and supporting long-term growth.
Prime Plasma Location: The Property is positioned less than one mile from Weber State University (an enrollment of over 32,000 students) where the property benefits from a strong and consistent flow of student, faculty, and community traffic.
Highly-Trafficked Corridor: The Property is prominently positioned in a highly trafficked corridor with excellent access and visibility along Harrison Boulevard, a primary north-south arterial roadway in Ogden, featuring approximately 30,500 vehicles per day (VPD).
High Ranking Brand: This location ranks in the top 81st percentile nationwide and 100th percentile in the City.
Essential Healthcare Use: Plasma-derived therapies such as immune deficiencies, pulmonary disorders, infectious diseases, and critical care conditions, creating durable global demand for plasma supply.
FDA-Regulated Facility: Plasma collection centers operate under strict FDA regulatory oversight, requiring licensing, quality protocols, and compliance procedures that create significant barriers to entry for new operators.
Recession-Resilient Industry: Demand for plasma-derived therapies remains consistent across economic cycles due to their critical role in treating chronic and life-threatening medical conditions.
Strong Industry Fundamentals: The plasma collection industry benefits from limited competition, regulatory oversight, and high barriers to entry, supporting long-term operational stability.
Mission-Critical Healthcare Infrastructure: Plasma donation centers serve as a critical first step in the manufacturing of plasma-derived therapies used worldwide, making these facilities essential components of the global healthcare supply chain.

Navigation Menu

Key Information

Highlights

Photos

Location

Agents

Broker of Record

Kyle Matthews